When Should Boys With CAH Begin TART Ultrasound Screening?
At a Glance
For boys with congenital adrenal hyperplasia, TART screening is often considered around puberty, commonly at ages 10 to 12, using testicular ultrasound. Earlier or closer monitoring may be needed with poor hormone control, and early detection may help protect fertility.
In this answer
3 sections
Testicular adrenal rest tumors (TARTs) are non-cancerous masses that develop inside the testicles of some males with congenital adrenal hyperplasia (CAH) [1]. These tumors grow from cells in the testes that are very similar to adrenal gland tissue [1]. Screening for TARTs typically begins around puberty—often considered around ages 10 to 12—using an ultrasound, though some high-risk boys may start earlier [2]. The goal of screening is to detect these masses early so your care team can monitor them and help protect your son’s long-term fertility.
Important Safety Warning: While TARTs are non-cancerous, any new lump, asymmetry, persistent enlargement, or unexplained testicular pain should be evaluated by a doctor promptly. Do not assume a new lump is a TART; other conditions, including testicular torsion (which causes sudden, severe pain) or testicular cancer, require urgent assessment [3].
Why Do TARTs Develop?
In males with CAH, an enzyme defect impairs the body’s ability to produce cortisol. To compensate, the pituitary gland in the brain produces high levels of ACTH (adrenocorticotropic hormone) to stimulate the adrenal glands [1].
However, some cells inside the testes also have receptors that respond to ACTH [4]. Chronic exposure to high ACTH levels can cause these adrenal-like cells to grow and multiply, forming TARTs [5][1]. While poor hormonal control and higher ACTH levels are strongly linked to tumor growth, TARTs can sometimes develop even in boys whose CAH appears well-managed [5][6].
Are TARTs Dangerous?
When a diagnosis of TART is confirmed, these masses are benign, meaning they are not cancer and will not spread to other parts of the body [1].
However, they do pose a risk to your son’s future fertility. TARTs are often bilateral (occurring in both testicles) and typically grow near the rete testis and seminiferous tubules—the delicate tubes inside the testicle responsible for producing and transporting sperm [2]. As the tumors expand, they can physically compress or obstruct these sperm-carrying tubes [2].
If left untreated for long periods, large or persistent TARTs can cause potentially irreversible damage, including permanent scarring (fibrosis) and testicular atrophy [7][2]. Among adult men with CAH who develop TARTs, studies show higher rates of severe oligospermia (low sperm count) or azoospermia (no sperm in the semen) compared to those without TARTs (e.g., 70% vs 3.6% in one adult cohort) [8].
Early detection is key because adjusting glucocorticoids (the steroid medications used to treat CAH) under strict medical supervision can sometimes shrink early-stage tumors and reduce the risk of progression [7][9]. However, outcomes vary, and established scarring may not be reversible [7].
Do Not Adjust Medications on Your Own: Never increase or change your son’s glucocorticoid doses without the endocrinologist’s supervision. Aggressively trying to suppress ACTH with excessive steroids can cause major side effects, and inadequate doses can lead to an adrenal crisis. Treatment decisions must balance tumor control with steroid-related risks.
Screening Guidelines and Monitoring
Because early-stage TARTs are usually too small to be felt during a physical exam and rarely cause symptoms, imaging is required to find them [3][10].
- When to start: Routine screening with a testicular ultrasound is often considered around puberty (ages 10 to 12) [2]. However, there is no single universal start age. Some guidelines suggest starting earlier if a boy has signs of early puberty, advanced bone age (when bones mature faster than chronological age), or prolonged periods of poor hormonal control [11][12].
- How often to screen: Follow-up intervals vary based on age, symptoms, CAH severity, and local clinic practices. Some centers recommend annual ultrasounds once screening begins, while others adjust the frequency based on clinical need [13][14].
- The ultrasound experience: Testicular ultrasound is completely noninvasive and uses no radiation. The clinical team can help ensure the exam is done comfortably, with a parent or chaperone present, respecting your son’s privacy.
- Routine exams: Even when ultrasounds aren’t scheduled, testicular physical exams and puberty assessments are a standard part of routine endocrinology visits.
Common questions in this guide
What are TARTs, and are they cancer?
When should a boy with CAH have his first TART ultrasound?
How often should TART screening ultrasounds be repeated?
Can TARTs affect fertility?
Can CAH medicine make TARTs smaller?
When should testicular pain or a lump in a boy with CAH be checked?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Screening timing
Should my son start TART ultrasound screening now, or wait until around puberty?
Screening schedule
How often would my son need testicular ultrasounds once screening begins?
Warning signs
What signs would mean my son should be checked sooner between screenings?
Related questions
Show more
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment.
Engels M, Span PN, van Herwaarden AE, et al.
Endocrine reviews 2019; (40(4)):973-987 doi:10.1210/er.2018-00258.
PMID: 30882882 - 2
Prepubertal Screening for Testicular Adrenal Rest Tumors in Boys with Classic Congenital Adrenal Hyperplasia: Emerging Evidence and Practical Implications.
Ranieri A, Ferrari V, Ortolano R, et al.
Children (Basel, Switzerland) 2026; (13(8)) doi:10.3390/children13081003.
PMID: 42650343 - 3
Testicular adrenal rest tumor in a pediatric patient with congenital adrenal hyperplasia: A case report.
Ibdah MG, Tos SM, Giacaman N, et al.
Radiology case reports 2023; (18(11)):4149-4152 doi:10.1016/j.radcr.2023.08.081.
PMID: 37745756 - 4
GATA transcription factors in testicular adrenal rest tumours.
Engels M, Span PN, Mitchell RT, et al.
Endocrine connections 2017; (6(8)):866-875 doi:10.1530/EC-17-0215.
PMID: 29038332 - 5
Hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia: a retrospective multicenter cohort study.
Schröder MAM, Neacşu M, Adriaansen BPH, et al.
European journal of endocrinology 2023; (189(4)):460-468 doi:10.1093/ejendo/lvad143.
PMID: 37837609 - 6
Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia.
Yu MK, Jung MK, Kim KE, et al.
Annals of pediatric endocrinology & metabolism 2015; (20(3)):155-61 doi:10.6065/apem.2015.20.3.155.
PMID: 26512352 - 7
Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors.
Jha S, El-Maouche D, Marko J, et al.
Journal of the Endocrine Society 2019; (3(12)):2290-2294 doi:10.1210/js.2019-00227.
PMID: 31745525 - 8
Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.
Bouvattier C, Esterle L, Renoult-Pierre P, et al.
The Journal of clinical endocrinology and metabolism 2015; (100(6)):2303-13 doi:10.1210/jc.2014-4124.
PMID: 25822101 - 9
Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
King TF, Lee MC, Williamson EE, Conway GS
Clinical endocrinology 2016; (84(6)):830-6 doi:10.1111/cen.13001.
PMID: 26666213 - 10
Sonographic Appearance of Testicular Adrenal Rest Tumour in a Patient with Congenital Adrenal Hyperplasia.
Deshpande SS, Shetty D, Saifi S
Polish journal of radiology 2017; (82()):526-529 doi:10.12659/PJR.902013.
PMID: 29662583 - 11
Bone age advancement is associated with testicular adrenal rest tumors in boys with congenital adrenal hyperplasia.
Gürbüz E, Kocaay P, Cetin SK, et al.
Journal of endocrinological investigation 2026; doi:10.1007/s40618-026-02984-3.
PMID: 42440236 - 12
Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors.
Vaid S, Kulkarni S, Marko J, et al.
The Journal of clinical endocrinology and metabolism 2026; (111(3)):698-706 doi:10.1210/clinem/dgaf498.
PMID: 40921717 - 13
Growth Pattern and Clinical Profile of Indian Children with Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia on Treatment.
Meena H, Jana M, Singh V, et al.
Indian journal of pediatrics 2019; (86(6)):496-502 doi:10.1007/s12098-018-02848-6.
PMID: 30697677 - 14
Testicular adrenal rest tumors in children with congenital adrenal hyperplasia.
Al-Ghamdi WM, Shazly MA, Al-Agha AE
Saudi medical journal 2021; (42(9)):986-993 doi:10.15537/smj.2021.42.9.20210257.
PMID: 34470837
This page explains TART screening in congenital adrenal hyperplasia for informational purposes only and does not constitute medical advice. Ask your endocrinology team about screening timing, and seek prompt care for a new lump or sudden testicular pain.